Melatonin: Wunderhormon oder Verbindung ohne therapeutischen Wert?

Deutsche Apotheker Zeitung

Volumn 136, Issue 20, 1996, Pages 17-24

  Steinhilber, Dieter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 ALLYL 4 OXO 2 THIAZOLIDINYLIDENE) 4 METHYLTHIOSEMICARBAZONE; 5 METHOXYLUZINDOLE; ANTIOXIDANT; HYPNOTIC AGENT; IMMUNOMODULATING AGENT; LUZINDOLE; MELATONIN; N ACETYLTRYPTAMINE; PSYCHOTROPIC AGENT; SEDATIVE AGENT; UNCLASSIFIED DRUG;

CANCER; CARDIOVASCULAR DISEASE; CATARACT; CIRCADIAN RHYTHM; DEPRESSION; DRUG INDICATION; DRUG MECHANISM; EPILEPSY; HUMAN; REVIEW; SLEEP DISORDER;

EID: 0344505508     PISSN: 00119857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. McCord, C P., F. P Allen: Evidences associating pineal gland function with alterations in pigmentation. J. Exp Zool 23, 207-224 (1917).
2. Lerner, A. B., J. D Case, R. V Heinzelman: Structure of melatonin. J. Am. Chem. Soc. 81, 6084-6085 (1959).
3. Pierpaoli, W., W. Regelson: Pineal control of aging: Effect of melatonin and pineal grafting on aging mice. Proc. Natl. Acad. Sci. USA 91, 787-791 (1994).
4. Coon, J. L., et al.: Pineal Serotonin N-Acetyltransferase: Expression cloning and molecular analysis Science 270, 1681-1683 (1995)
5. Reppert, S M , D R. Weaver: Melatonin madness Cell 83, 1059-1062 (1996).
6. Reiter, R. J.: The melatonin rhythm both a clock and a calendar. Experientia 49, 654-664 (1993).
7. Dawson, D., N Encel: Melatonin and sleep in humans. S. Pineal Res. 15, 1-12 (1993).
8. Arendt, J., et al.: The effects of jet-lag and their alleviation by melatonin. Ergonomics 30, 1379-1393 (1987).
9. Webb, S. M., M. Puig-Domingo: Role of melatonin in health and disease. Clin. Endocrinol. 42, 221-234 (1995).
10. Waldhauser, F., B. Ehrhart, E Förster. Clinical aspects of the melatonin action: impact of development, aging, puberty, involvement of melatonin in psychiatric disease and importance of neuroendocrine interactions. Experientia 49, 671-681 (1993).
11. Reiter, R. J., A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18, 1-11 (1995).
12. Barlow-Waldem, L R., et al.: Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int. 26, 497-502 (1995).
13. Abe, M., et al.: Inhibitory effect of melatonin on cataract formation in newborn rats: Evidence for an antioxidative role for melatonin. J. Pineal Res. 17, 94-100 (1994).
14. Blinkenstaff, R T., et al.: Potential radioprotective agents. 1. Homologs of melatonin. J. Pharm Sci. 83, 216-218 (1994).
15. Dubocovich, M. L : Melatonin receptors: Are there multiple subtypes? Trends Pharmacol. Sci. 16, 50-56 (1995).
16. Sugden, D.: Melatonin: Binding site characteristics and biochemical and cellular responses. Neurochem Int. 24, 147-157 (1994).
17. Morgan, P. J., et al.: Melatonin receptors Localization, molecular pharmacology and physiological significance. Neurochem. Int. 24, 101-146 (1994).
18. Reppert, S. M , D R Weaver, T. Ebisawa: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13, 1177-1185 (1994).
19. Reppert, S. M., et al.: Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel(1b) melatonin receptor. Proc Natl. Acad. Sci. USA 92, 8734-8738 (1995).
20. Becker-André, M , et al.: Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol. Chem. 269, 28531-28534 (1994).
21. Becker-André, M. E. André, J. F. DeLamarter: Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem. Biophys. Res. Commun. 194, 1371-1379 (1993).
22. Giguère, V. et al.: Isoform-specific amino-terminal domains dictate DNA-binding properties of RORα, a novel family of orphan hormone nuclear receptors Genes Dev. 8, 538-553 (1994).
23. Steinhilber, D., et al.: The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J. Biol. Chem. 270, 7037-7040 (1995).
24. Steinhilber, D.: 5-Lipoxygenase: enzyme expression and regulation of activity. Pharm. Acta Helv. 69, 3-14 (1994)
25. Jakobsson, P. J., et al.: On the expression and regulation of 5-lipoxygenase in human lymphocytes Proc. Natl. Acad Sci USA 89, 3521-3525 (1992).
26. Steinhilber, D., O. Rådmark, B. Samuelsson: Transforming growth factor beta upregulates 5-lipoxygenase activity during myeloid cell maturation. Proc. Natl. Acad. Sci USA 90, 5984-5988 (1993)
27. 3 Proc. Natl. Acad. Sci. USA 92, 107-111 (1995).
28. Wiesenberg, I , et. al., Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand Nucleic Acids Res. 23, 327-333 (1995).
29. Maestroni, G.: T-helper-2 lymphocytes as a peripheral target of melatonin. J. Pineal Res. 18, 84-89 (1995).
30. Lopez, G.M., et al , Melatonin potentiates cyclic AMP production stimulated by vasoactive intestinal peptide in human lymphocytes. Neurosci. Lett. 136, 150-152 (1992)
31. Morrey, M.K., et al.: Activation of human monocytes by the pineal hormone melatonin. J. Immunol 153, 2671-2680 (1994).
32. Colombo, L.L., et al.: Melatonin induced increase in gamma-interferon production by murine splenocytes. Immunol. Lett 33, 123-126 (1992)
33. Poon, A.M., et al : Evidence for a direct action of melatonin on the immune system Biol. Signals 3, 107-117 (1994)
34. BgVV: Melatonin kein Nahrungserganzungsmittel. Dtsch. Apoth. Ztg. 135, 4220-4222 (1995)